Replimune Group, Inc. 4

CEO Sushil Patel sold 39,341 shares of Replimune Group, Inc. common stock on 2026-08-10 at about $12.97 per share to cover taxes from PSU vesting, leaving him with 708,151 shares.

On August 10, 2026, Replimune Group, Inc. CEO Sushil Patel reported the sale of 39,341 shares of common stock at an average price of $12.97 per share, in a transaction explicitly described as a non-discretionary "sell to cover" to satisfy tax withholding obligations arising from the vesting of performance-based restricted stock units. The sale totaled approximately $510,000 in value and reduced his direct holdings to 708,151 shares of common stock. Because the disposition was executed under an irrevocable sell-to-cover provision tied to equity compensation rather than an open-market discretionary trade, it is more indicative of routine tax-related activity than of a change in sentiment regarding the company’s prospects.

Filing Facts

CIK

1737953

Ticker

REPL

Form

4

Source Type

fda

Accession

0001104659-26-095012

Alert Tier

5